 HTLV-I/II seroprevalence HIV/HTLV coinfection intravenous drug users Data multiyear seroprevalence survey human T-lymphotropic virus types II HTLV-I/II intravenous drug users locations demographic patterns seropositivity coinfection human immunodeficiency virus type Seropositivity HTLV-I/II whole-virus enzyme Western blot confirmation subjects methadone maintenance detoxification clinics HTLV-I/II Seropositivity HTLV-I/II varied racial group age sex geographic location Blacks age- location-adjusted infection rate whites seropositivity strong gradient age Females rate males adjustment age location locations rate Miami Baltimore Los Angeles former rates subjects occurrence coinfection HTLV-I/II chance